A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III.

作者信息

Mulatero Paolo

出版信息

J Clin Endocrinol Metab. 2008 Aug;93(8):2972-4. doi: 10.1210/jc.2008-1241.

DOI:10.1210/jc.2008-1241

PMID:18685118

Abstract

摘要

相似文献

A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III.

J Clin Endocrinol Metab. 2008 Aug;93(8):2972-4. doi: 10.1210/jc.2008-1241.

Serum 18-hydroxycortisol in primary aldosteronism, hypertension, and normotensives.

Hypertension. 2001 Sep;38(3 Pt 2):688-91. doi: 10.1161/01.hyp.38.3.688.

SFE/SFHTA/AFCE consensus on primary aldosteronism, part 5: Genetic diagnosis of primary aldosteronism.

Ann Endocrinol (Paris). 2016 Jul;77(3):214-9. doi: 10.1016/j.ando.2016.02.006. Epub 2016 Jun 15.

In familial hyperaldosteronism type I, hybrid gene-induced aldosterone production dominates that induced by wild-type genes.

J Clin Endocrinol Metab. 1997 Nov;82(11):3670-6. doi: 10.1210/jcem.82.11.4365.

[Glucocorticoid suppressing aldosteronism].

Nihon Naika Gakkai Zasshi. 2006 Apr 10;95(4):668-70. doi: 10.2169/naika.95.668.

Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene.

J Clin Endocrinol Metab. 2001 Oct;86(10):4805-7. doi: 10.1210/jcem.86.10.7920.

Familial hyperaldosteronism type 1 in pregnancy.

Intern Med J. 2009 Feb;39(2):135-6. doi: 10.1111/j.1445-5994.2008.01869.x.

Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland.

J Appl Genet. 2005;46(3):329-32.

Saga of Familial Hyperaldosteronism: Yet a New Channel.

Hypertension. 2018 Jun;71(6):1010-1014. doi: 10.1161/HYPERTENSIONAHA.118.11150. Epub 2018 May 7.

Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree.

J Clin Endocrinol Metab. 2002 Jul;87(7):3187-91. doi: 10.1210/jcem.87.7.8647.

引用本文的文献

Who should be screened for primary aldosteronism? A comprehensive review of current evidence.

J Clin Hypertens (Greenwich). 2022 Sep;24(9):1194-1203. doi: 10.1111/jch.14558.

Progress on Genetic Basis of Primary Aldosteronism.

Biomedicines. 2021 Nov 17;9(11):1708. doi: 10.3390/biomedicines9111708.

Biochemical, Histopathological, and Genetic Characterization of Posture-Responsive and Unresponsive APAs.

J Clin Endocrinol Metab. 2020 Sep 1;105(9):e3224-35. doi: 10.1210/clinem/dgaa367.

Pathogenesis of Familial Hyperaldosteronism Type II: New Concepts Involving Anion Channels.

Curr Hypertens Rep. 2019 Apr 4;21(4):31. doi: 10.1007/s11906-019-0934-y.

Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.

Clin Endocrinol (Oxf). 2016 Dec;85(6):845-851. doi: 10.1111/cen.13132. Epub 2016 Jul 12.

Prevalence and characterization of somatic mutations in Chinese aldosterone-producing adenoma patients.

Medicine (Baltimore). 2015 Apr;94(16):e708. doi: 10.1097/MD.0000000000000708.

Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: a population-based study from Western Norway.

Langenbecks Arch Surg. 2013 Aug;398(6):869-74. doi: 10.1007/s00423-013-1093-2. Epub 2013 Jun 19.

Role of KCNJ5 in familial and sporadic primary aldosteronism.

Nat Rev Endocrinol. 2013 Feb;9(2):104-12. doi: 10.1038/nrendo.2012.230. Epub 2012 Dec 11.

Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.

J Clin Endocrinol Metab. 2012 Aug;97(8):E1567-72. doi: 10.1210/jc.2011-3132. Epub 2012 May 24.

A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension.

J Clin Endocrinol Metab. 2012 Aug;97(8):E1532-9. doi: 10.1210/jc.2012-1334. Epub 2012 May 24.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验